Join us for this special interview with Keith Boettiger, President of Abbott Neuromodulation. Mr. Boettiger walks us through his career, which started as a graduate of The Johns Hopkins University nursing program and eventually lead to leadership in the medical device field. The chat also covered the very recent launch of FDA-approved NeuroSphere virtual clinic, a first-of-its-kind remote neuromodulation patient-care technology in the U.S. for patients seeking relief from chronic pain and movement conditions. A true success story of a dedicated leader bringing the best to the market for patient care.
Links:
- https://www.statesman.com/story/news/healthcare/2021/03/08/abbotts-neuromodulation-group-gets-fda-approval-chronic-pain-app/4620321001/
- https://medcitynews.com/2021/03/fda-approval-brings-remote-programming-for-abbotts-deep-brain-stimulation-device/
- https://firstwordhealthtech.com/story/5242989